Experimental or ancillary medicinal products authorised when used under the provisions of 1° or 2° of III of article L. 1121-16-1 may be dispensed by pharmacies, if they appear on the list referred to in the first paragraph of article L. 162-17 of the Social Security Code, and provided that :
1° The persons taking part in the research have the same characteristics as those covered by the authorised indication;
2° The design of the research does not require special manufacturing or packaging;
3° This research concerns medicinal products which, as part of the treatment, are dispensed in pharmacies;
4° The patients would have received these medicinal products if they had not been included in these clinical trials;
5° The sponsor has set up specific methods for monitoring compliance and traceability;
6° Compliance and traceability rules, the details of which are specified by order of the Minister for Health, have been complied with.